0
Poster Presentations: Wednesday, October 26, 2011 |

Resveratrol Ameliorates Mitochondrial and Tissue Damage in Pulmonary Ischemia Reperfusion Injury FREE TO VIEW

Sebastian-Patrick Sommer, MD; Stefanie Sommer, MD; Bhanu Sinha, PhD; Daniel Schäfer, DrPH; Christoph Otto, PhD; Ivan Aleksic, PhD; Anne Sophie Mehdorn, MDS; Rainer Leyh, PhD
Author and Funding Information

University Hospital Würzburg, Würzburg, Germany



Chest. 2011;140(4_MeetingAbstracts):659A. doi:10.1378/chest.1085989
Text Size: A A A
Published online

Abstract

PURPOSE: We have demonstrated impaired mitochondrial viability and function during pulmonary ischemia reperfusion injury(IR). Resveratrol(Res) has demonstrated to ameliorate the IR of various organs. This study analyzes the impact of Res-preconditioning on pulmonary IR-induced mitochondrial dysfunction and tissue damage.

METHODS: Rats (n=6,each) were subjected to controls, Shams without(Sham) or with preconditioning by 5µg Res i.v.(Res-Sham) and two study group conditions receiving IR without(IR) or with Res-preconditioning(Res-IR). IR was induced by 30min of left pulmonary clamping, followed by 60min reperfusion-time. Respiratory chain complex activities(I-V,II-V,III-V) were analyzed in isolated mitochondria (polarography). Mitochondrial membrane potential (ΔΨm) was determined in JC1-stained mitochondria after energizing and 0 to 3 min after uncoupling (FACS). Viability testing was performed using Ca2+-induced swelling (Photometry). Cytochrome C (CytC) liberation was detected (ELISA). Tissue was analyzed for matrix-metalloproteinase-9 (MMP-9) activity (Zymography), myeloperoxidase (MPO) activity and GSH content and oxidation (Colorimetry). Statistical analysis was performed in terms of ANOVA.

RESULTS: Comparing to controls IR impaired mitochondrial viability(P<.001 ). Viability was preserved by RES(P<.001 ). Swelling was inhibited in Res-Sham. In comparison to controls, IR derogated respiratory chain-function(I-V:P<.01;II-V:P<.01;III-V:P<.01) but complex-activities were preserved in Res-IR (I-V:P< 0.05;II-V:P<.05;III-V:P<.05). ΔΨm demonstrated hyper-polarization combined with increased ΔΨm-susceptibility against uncoupling in IR, Res-Sham and Res-IR(all P>.05). In IR MMP-9(P<.001), CytC-liberation(P<.001) and MPO-activities(P<.001) were increased but Res-preconditioning protected from MMP-9-(P<.01), MPO-activation(P<.05) and CytC-liberation(P>.05). In IR, observed decay in total GSH(P<.001) was insignificantly ameliorated by Res-IR(P>.05)

CONCLUSIONS: During IR, Res protects from mitochondria-induced tissue injury, oxidative stress, tissue degradation and inflammation. Disorder of ΔΨm appeared to be adverted by Res.

CLINICAL IMPLICATIONS: Res appears to be a promising drug to prevent pulmonary grafts from IR.

DISCLOSURE: The following authors have nothing to disclose: Sebastian-Patrick Sommer, Stefanie Sommer, Bhanu Sinha, Daniel Schäfer, Christoph Otto, Ivan Aleksic, Anne Sophie Mehdorn, Rainer Leyh

This study evaluates the clinical impact of the chemical compund Resveratrol in the setting of the pulmonary ischemia reperfusion injury.

09:00 AM - 10:00 AM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543